Please log in [My Account], to introduce majorlens to your friends.
MiSight 1 day - the first soft contact lenses proven to slow the progression of short-sightedness (myopia) in children.
MiSight 1 day is FDA-approved for slowing the progression of myopia (nearsightedness or short-sightedness) in children, who at initiation of treatment are 8-12 years of age.
According to a study published in Clinical Ophthalmology in August 2018, 41.9% of U.S. children ages 5-19 are myopic. This is due in part to changing lifestyles, with children spending less time outdoors and more time spent focusing on close objects such as digital screens.
Contact lenses are a medical device and care must be taken when ordering.
When you place an order with us, please make sure to choose the prescription that was given to you by an ophthalmologist or qualified physician in the u.s.
[majorlens]strongly suggests having your eyes checked periodically or as directed by your physician.